The primary goal of HD123 is to derive biomarkers that could be further developed to measure the efficacy of novel pharmacological treatments for Huntington’s disease (HD).

What is a biomarker? A biomarker is a measurable indicator of a disease or condition. It can for instance be a level of something in your blood or hormon levels. Biomarkers are often measured and evaluated to examine normal biological processes – like measuring the level of hemoglobin in your blood or your blood pressure. In reference to research on Huntingtons disease, a biomarker can tell us something about disease progression – potentially even before symptoms are visible.

Estimated Study Completion Date: 31 March, 2024